Selected research
Industry Research
Veterinary Therapeutics Industry Research Report 2026
Market perspective
The global Veterinary Therapeutics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Veterinary Therapeutics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Veterinary Therapeutics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Veterinary Therapeutics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Veterinary Therapeutics include CAHIC, Zoetis, Ringpu Biology, Merck, Virbac, Vetoquinol, Phibro, Ouro Fino Saude and Orion, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Veterinary Therapeutics market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Veterinary Therapeutics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Therapeutics Market by Company
CAHIC
Zoetis
Ringpu Biology
Merck
Virbac
Vetoquinol
Phibro
Ouro Fino Saude
Orion
Norbrook
Nippon Zenyaku Kogyo
Huvepharma
Hipra
Farmavet-Pasteur
Elanco
Dechra
Ceva
Boehringer Ingelheim
Veterinary Therapeutics Segment by Type
Analgesics
Sedatives
Anti-Inflammatory
Parasiticides
Anti-Infectives
Others
Veterinary Therapeutics Segment by Application
Swine
Cattle
Poultry
Pets
Others
Veterinary Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Veterinary Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Analgesics
- Sedatives
- Anti-Inflammatory
- Parasiticides
- Anti-Infectives
- Others
Applications
- Swine
- Cattle
- Poultry
- Pets
- Others
Companies covered
- CAHIC
- Zoetis
- Ringpu Biology
- Merck
- Virbac
- Vetoquinol
- Phibro
- Ouro Fino Saude
- Orion
- Norbrook
- Nippon Zenyaku Kogyo
- Huvepharma
- Hipra
- Farmavet-Pasteur
- Elanco
- Dechra
- Ceva
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Veterinary Therapeutics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Analgesics
- 2.2.3 Sedatives
- 2.2.4 Anti-Inflammatory
- 2.2.5 Parasiticides
- 2.2.6 Anti-Infectives
- 2.2.7 Others
- 2.3 Veterinary Therapeutics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Swine
- 2.3.3 Cattle
- 2.3.4 Poultry
- 2.3.5 Pets
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Veterinary Therapeutics Breakdown Data by Type
- 3.1 Global Veterinary Therapeutics Historic Market Size by Type (2021-2026)
- 3.2 Global Veterinary Therapeutics Forecasted Market Size by Type (2027-2032)
4 Veterinary Therapeutics Breakdown Data by Application
- 4.1 Global Veterinary Therapeutics Historic Market Size by Application (2021-2026)
- 4.2 Global Veterinary Therapeutics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Veterinary Therapeutics Market Perspective (2021-2032)
- 5.2 Global Veterinary Therapeutics Growth Trends by Region
- 5.2.1 Global Veterinary Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Veterinary Therapeutics Historic Market Size by Region (2021-2026)
- 5.2.3 Veterinary Therapeutics Forecasted Market Size by Region (2027-2032)
- 5.3 Veterinary Therapeutics Market Dynamics
- 5.3.1 Veterinary Therapeutics Industry Trends
- 5.3.2 Veterinary Therapeutics Market Drivers
- 5.3.3 Veterinary Therapeutics Market Challenges
- 5.3.4 Veterinary Therapeutics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Veterinary Therapeutics Players by Revenue
- 6.1.1 Global Top Veterinary Therapeutics Players by Revenue (2021-2026)
- 6.1.2 Global Veterinary Therapeutics Revenue Market Share by Players (2021-2026)
- 6.2 Global Veterinary Therapeutics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Veterinary Therapeutics Head Office and Area Served
- 6.4 Global Veterinary Therapeutics Players, Product Type & Application
- 6.5 Global Veterinary Therapeutics Manufacturers Established Date
- 6.6 Global Veterinary Therapeutics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Veterinary Therapeutics Market Size (2021-2032)
- 7.2 North America Veterinary Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Veterinary Therapeutics Market Size by Country (2021-2026)
- 7.4 North America Veterinary Therapeutics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Veterinary Therapeutics Market Size (2021-2032)
- 8.2 Europe Veterinary Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Veterinary Therapeutics Market Size by Country (2021-2026)
- 8.4 Europe Veterinary Therapeutics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Veterinary Therapeutics Market Size (2021-2032)
- 9.2 Asia-Pacific Veterinary Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Veterinary Therapeutics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Veterinary Therapeutics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Veterinary Therapeutics Market Size (2021-2032)
- 10.2 South America Veterinary Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Veterinary Therapeutics Market Size by Country (2021-2026)
- 10.4 South America Veterinary Therapeutics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Veterinary Therapeutics Market Size (2021-2032)
- 11.2 Middle East & Africa Veterinary Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Veterinary Therapeutics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Veterinary Therapeutics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 CAHIC
- 12.1.1 CAHIC Company Information
- 12.1.2 CAHIC Business Overview
- 12.1.3 CAHIC Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.1.4 CAHIC Veterinary Therapeutics Product Portfolio
- 12.1.5 CAHIC Recent Developments
- 12.2 Zoetis
- 12.2.1 Zoetis Company Information
- 12.2.2 Zoetis Business Overview
- 12.2.3 Zoetis Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.2.4 Zoetis Veterinary Therapeutics Product Portfolio
- 12.2.5 Zoetis Recent Developments
- 12.3 Ringpu Biology
- 12.3.1 Ringpu Biology Company Information
- 12.3.2 Ringpu Biology Business Overview
- 12.3.3 Ringpu Biology Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.3.4 Ringpu Biology Veterinary Therapeutics Product Portfolio
- 12.3.5 Ringpu Biology Recent Developments
- 12.4 Merck
- 12.4.1 Merck Company Information
- 12.4.2 Merck Business Overview
- 12.4.3 Merck Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.4.4 Merck Veterinary Therapeutics Product Portfolio
- 12.4.5 Merck Recent Developments
- 12.5 Virbac
- 12.5.1 Virbac Company Information
- 12.5.2 Virbac Business Overview
- 12.5.3 Virbac Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.5.4 Virbac Veterinary Therapeutics Product Portfolio
- 12.5.5 Virbac Recent Developments
- 12.6 Vetoquinol
- 12.6.1 Vetoquinol Company Information
- 12.6.2 Vetoquinol Business Overview
- 12.6.3 Vetoquinol Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.6.4 Vetoquinol Veterinary Therapeutics Product Portfolio
- 12.6.5 Vetoquinol Recent Developments
- 12.7 Phibro
- 12.7.1 Phibro Company Information
- 12.7.2 Phibro Business Overview
- 12.7.3 Phibro Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.7.4 Phibro Veterinary Therapeutics Product Portfolio
- 12.7.5 Phibro Recent Developments
- 12.8 Ouro Fino Saude
- 12.8.1 Ouro Fino Saude Company Information
- 12.8.2 Ouro Fino Saude Business Overview
- 12.8.3 Ouro Fino Saude Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.8.4 Ouro Fino Saude Veterinary Therapeutics Product Portfolio
- 12.8.5 Ouro Fino Saude Recent Developments
- 12.9 Orion
- 12.9.1 Orion Company Information
- 12.9.2 Orion Business Overview
- 12.9.3 Orion Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.9.4 Orion Veterinary Therapeutics Product Portfolio
- 12.9.5 Orion Recent Developments
- 12.10 Norbrook
- 12.10.1 Norbrook Company Information
- 12.10.2 Norbrook Business Overview
- 12.10.3 Norbrook Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.10.4 Norbrook Veterinary Therapeutics Product Portfolio
- 12.10.5 Norbrook Recent Developments
- 12.11 Nippon Zenyaku Kogyo
- 12.11.1 Nippon Zenyaku Kogyo Company Information
- 12.11.2 Nippon Zenyaku Kogyo Business Overview
- 12.11.3 Nippon Zenyaku Kogyo Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.11.4 Nippon Zenyaku Kogyo Veterinary Therapeutics Product Portfolio
- 12.11.5 Nippon Zenyaku Kogyo Recent Developments
- 12.12 Huvepharma
- 12.12.1 Huvepharma Company Information
- 12.12.2 Huvepharma Business Overview
- 12.12.3 Huvepharma Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.12.4 Huvepharma Veterinary Therapeutics Product Portfolio
- 12.12.5 Huvepharma Recent Developments
- 12.13 Hipra
- 12.13.1 Hipra Company Information
- 12.13.2 Hipra Business Overview
- 12.13.3 Hipra Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.13.4 Hipra Veterinary Therapeutics Product Portfolio
- 12.13.5 Hipra Recent Developments
- 12.14 Farmavet-Pasteur
- 12.14.1 Farmavet-Pasteur Company Information
- 12.14.2 Farmavet-Pasteur Business Overview
- 12.14.3 Farmavet-Pasteur Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.14.4 Farmavet-Pasteur Veterinary Therapeutics Product Portfolio
- 12.14.5 Farmavet-Pasteur Recent Developments
- 12.15 Elanco
- 12.15.1 Elanco Company Information
- 12.15.2 Elanco Business Overview
- 12.15.3 Elanco Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.15.4 Elanco Veterinary Therapeutics Product Portfolio
- 12.15.5 Elanco Recent Developments
- 12.16 Dechra
- 12.16.1 Dechra Company Information
- 12.16.2 Dechra Business Overview
- 12.16.3 Dechra Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.16.4 Dechra Veterinary Therapeutics Product Portfolio
- 12.16.5 Dechra Recent Developments
- 12.17 Ceva
- 12.17.1 Ceva Company Information
- 12.17.2 Ceva Business Overview
- 12.17.3 Ceva Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.17.4 Ceva Veterinary Therapeutics Product Portfolio
- 12.17.5 Ceva Recent Developments
- 12.18 Boehringer Ingelheim
- 12.18.1 Boehringer Ingelheim Company Information
- 12.18.2 Boehringer Ingelheim Business Overview
- 12.18.3 Boehringer Ingelheim Revenue in Veterinary Therapeutics Business (2021-2026)
- 12.18.4 Boehringer Ingelheim Veterinary Therapeutics Product Portfolio
- 12.18.5 Boehringer Ingelheim Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst